Systemic reactions to imiquimod (Aldara)

被引：0
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2004年 / 46卷 / 1195期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
[21]   Severe Systemic Reaction to Topical Imiquimod [J].
Heikkinen, Anna-Kaisa ;
Susitaival, Paivikki .
ACTA DERMATO-VENEREOLOGICA, 2011, 91 (05) :594-595
[22]   The efficacy of imiquimod 5% cream (Aldara®) in the treatment of aural plaque in horses: a pilot open-label clinical trial [J].
Torres, Sheila M. F. ;
Malone, Erin D. ;
White, Stephen D. ;
Koch, Sandra N. ;
Watson, Johanna L. .
VETERINARY DERMATOLOGY, 2010, 21 (05) :503-509
[23]   Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in the treatment of COVID-19? [J].
Avcilar, Huseyin ;
Eken, Ahmet .
MEDICAL HYPOTHESES, 2020, 144
[24]   Systemic side effects from topical imiquimod [J].
Hanger, Carl ;
Dalrymple, Judith ;
Hepburn, David .
NEW ZEALAND MEDICAL JOURNAL, 2005, 118 (1223) :93-96
[25]   Use of imiquimod 5% cream (Aldara™) in cats with multicentric squamous cell carcinoma in situ:: 12 cases (2002-2005) [J].
Gill, V. L. ;
Bergman, P. J. ;
Baer, K. E. ;
Craft, D. ;
Leung, C. .
VETERINARY AND COMPARATIVE ONCOLOGY, 2008, 6 (01) :55-64
[26]   Graceway Pharmaceuticals and Aldara [J].
Heller, Marissa .
JOURNAL OF DRUGS IN DERMATOLOGY, 2008, 7 (06) :603-604
[27]   Local and systemic adverse effects to topical imiquimod due to systemic immune stimulation [J].
Kumar, Bhushan ;
Narang, Tarun .
SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 (05) :432-432
[28]   Scar management after breast surgery:: Preliminary results of a prospective, randomized, and double-blind clinical study with Aldara cream 5% (Imiquimod) [J].
Prado, A ;
Andrades, P ;
Benitez, S ;
Umaña, M .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2005, 115 (03) :966-972
[29]   Mycosis fungoides with systemic Administration of Bexarotene and local Application of Imiquimod [J].
Ruebben, A. .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09) :921-921
[30]   EXAGGERATED IMIQUIMOD APPLICATION SITE REACTIONS IN THE CONTEXT OF SYSTEMIC TUMOR NECROSIS FACTOR-ALPHA INHIBITION: MORE THAN A COINCIDENTAL OCCURRENCE? [J].
Saggini, A. ;
Saraceno, R. ;
Chimenti, S. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2011, 24 (02) :509-515
12345